U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671833) titled 'A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects' on April 14. Brief Sum... Read More
U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671261) titled 'SEEG-Guided DBS for Schizophrenia' on June 22. Brief Summary: This is a prospective, rando... Read More
New Delhi, June 27 -- In one of their Instagram videos from May, Bong Eats co-founder Insiya Poonawala can be seen carrying neatly packed boxes to a post office in Lisbon. It also has Saptarshi Chakra... Read More
Hyderabad, June 27 -- Former Telangana Director General of Police, Anjani Kumar, bagged a gold medal in the 25-meter centre fire pistol senior master men individual event at the state shooting champio... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eval... Read More